Please try another search
Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. The company operates in four segments: Pharmaceutical Wholesale Business, Dispensing Pharmacy Business, Pharmaceutical Manufacturing and Sales Business, and Other Peripheral Businesses. It sells prescription pharmaceuticals, test reagents, and testing equipment, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems, as well as maintenance services related to customer support systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Atsushi Udoh | 59 | 2016 | Representative Director & CEO |
Takeo Matsutani | 57 | 2005 | Director |
Shunsuke Watanabe | 79 | 2014 | Independent Outside Director |
Yoshiaki Kamoya | - | 2020 | Independent Outside Director |
Toshiharu Sakurai | - | - | VP & Director of Toho System Service Co., Ltd |
Masami Tada | 59 | 2020 | GM of Regulatory Affairs Division, GM of Quality Assurance Office & Director |
Hidehito Kotani | - | 2022 | Independent Outside Director |
Hiromi Edahiro | 71 | 2012 | Representative Director & CFO |
Akira Umada | 58 | 2016 | Senior Executive MD, COO, Head of Sales & Director |
Akihiko Nakahara | - | - | President & Representative Director of Koyo Co., Ltd |
Kentaro Murakawa | 64 | 2022 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review